Valuation: Virbac

Market Cap 2.77B 3.23B 2.59B 2.37B 4.46B 309B 4.53B 30.51B 11.95B 155B 12.12B 11.86B 512B P/E 2026 *
16.2x
P/E 2027 * 14.7x
Enterprise Value 2.9B 3.38B 2.7B 2.48B 4.66B 323B 4.74B 31.9B 12.49B 162B 12.67B 12.4B 535B EV / Sales 2026 *
1.87x
EV / Sales 2027 * 1.73x
Free-Float
49.03%
Yield 2026 *
0.52%
Yield 2027 * 0.62%
1 day+0.15%
1 week-0.90%
Current month-2.07%
1 month+1.38%
3 months-7.03%
6 months-9.95%
Current year-7.55%
1 week 326
Extreme 326
334.5
1 month 326
Extreme 326
350
Current year 312.5
Extreme 312.5
389.5
1 year 296
Extreme 296
389.5
3 years 239
Extreme 239
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 2025-08-31
Chief Executive Officer 50 2024-09-26
Chief Operating Officer 64 2021-12-31
Director TitleAgeSince
Chairman 61 2006-03-31
Director/Board Member 68 2010-07-27
Director/Board Member 65 2017-09-04
Date Insider Type Main position Quantity % Market Cap.
4/22/24 Sell

Chief Executive Officer

810 0.0096%
4/22/24 Sell

Chief Executive Officer

140 0.0017%
4/22/24 Sell

Chief Executive Officer

1,688 0.0200%
Change 5-day change 1-year change 3-year change Capi.($)
+0.15%-0.90%-1.93%+21.28% 3.2B
+3.68%+4.27%-50.74%-57.77% 30.56B
+3.64%+10.71%+39.84%+110.84% 11.81B
-2.19%-0.70%-17.53%+5.74% 3.95B
-2.52%-4.51%+43.34%+37.20% 2.18B
+0.86%+0.43%+12.26%+11.90% 1.94B
+2.28%+4.85%+11.27%+133.93% 1.41B
-2.28%-7.21%-20.99%+4.19% 1.27B
-1.91%+0.30%-12.91%-42.95% 1.03B
+1.13%+0.42%-5.66%-21.30% 954M
Average +0.28%+1.08%-0.30%+20.31% 5.83B
Weighted average by Cap. +2.45%+4.32%-18.30%-2.27%

Financials

2026 *2027 *
Net sales 1.55B 1.81B 1.45B 1.33B 2.5B 173B 2.54B 17.09B 6.69B 86.67B 6.79B 6.64B 287B 1.65B 1.92B 1.54B 1.41B 2.65B 184B 2.7B 18.15B 7.11B 92.06B 7.21B 7.05B 304B
Net income 171M 199M 160M 147M 276M 19.07B 280M 1.89B 738M 9.56B 749M 733M 31.62B 190M 221M 177M 162M 305M 21.12B 310M 2.09B 818M 10.59B 830M 812M 35.02B
Net Debt 127M 148M 118M 109M 204M 14.12B 208M 1.4B 547M 7.08B 555M 543M 23.42B 75.16M 87.62M 70.18M 64.39M 121M 8.37B 123M 828M 324M 4.2B 329M 322M 13.89B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
26-08-19 €330.50 +0.15% 1,804
26-08-18 €330.00 +0.30% 3,490
26-08-17 €329.00 -1.05% 1,965
26-08-14 €332.50 +0.30% 1,338
26-08-13 €331.50 -0.60% 1,961
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
330.50EUR
Average target price
411.88EUR
Spread / Average Target
+24.62%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock